\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ hypertension\\.\ \(0\)\
\-\ complex\\,\\ round\\,\\ heterogeneously\\ enhancing\\ mass\\ measuring\\ approximately\\ 5\\.5\\ x\\ 5\\.5\\ cm\\ and\\ positioned\\ anterior\\ to\\ the\\ ivc\\ and\\ inferior\\ to\\ the\\ third\\ portion\\ of\\ the\\ duodenum\\.\ \(0\)\
\-\ extra\\ adrenal\\ pheochromocytoma\\ \\(paraganglioma\\)\ \(0\)\
\-\ retroperitoneal\\ sarcoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ solitary\\ enlarged\\ lymph\\ node\ \(0\)\
\-\ smooth\\ muscle\\ tumor\\ associated\\ with\\ duodenum\ \(0\)\
\-\ 66\\ yo\\ male\\ presents\\ to\\ urology\\ service\\ with\\ history\\ of\\ hematuria\\ and\\ pyelonephritis\\.\ \(0\)\
\-\ during\\ surgical\\ resection\\,\\ the\\ patient\\ became\\ hypertensive\\ as\\ the\\ mass\\ was\\ manipulated\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ duodenum\\:\\ 0\\.32088483682567365\ \(0\)\
\-\ manipulated\\:\\ 0\\.23465215923987612\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.18438727382318287\ \(0\)\
\-\ urology\\:\\ 0\\.1790100338457846\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.17742104751587204\ \(0\)\
\-\ positioned\\:\\ 0\\.1766584850980201\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.16938881346682877\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.16938881346682877\ \(0\)\
\-\ hypertensive\\:\\ 0\\.16938881346682877\ \(0\)\
\-\ service\\:\\ 0\\.16881112925339922\ \(0\)\
\-\ the\\:\\ 0\\.1627346085728405\ \(0\)\
\-\ became\\:\\ 0\\.16001878998303434\ \(0\)\
\-\ ivc\\:\\ 0\\.1583843796626227\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.15721709938555764\ \(0\)\
\-\ 66\\:\\ 0\\.15297311898400012\ \(0\)\
\-\ adrenal\\:\\ 0\\.15106611941140374\ \(0\)\
\-\ solitary\\:\\ 0\\.1492783875654459\ \(0\)\
\-\ hematuria\\:\\ 0\\.1442582188835273\ \(0\)\
\-\ node\\:\\ 0\\.14019866501169317\ \(0\)\
\-\ extra\\:\\ 0\\.1370182351553377\ \(0\)\
\-\ sarcoma\\:\\ 0\\.1368307302473512\ \(0\)\
\-\ smooth\\:\\ 0\\.134671637389493\ \(0\)\
\-\ round\\:\\ 0\\.13365030039099576\ \(0\)\
\-\ lymph\\:\\ 0\\.126838148856495\ \(0\)\
\-\ measuring\\:\\ 0\\.1261867677053481\ \(0\)\
\-\ complex\\:\\ 0\\.1256761399216895\ \(0\)\
\-\ hypertension\\:\\ 0\\.1248039120700741\ \(0\)\
\-\ mass\\:\\ 0\\.12460950030544325\ \(0\)\
\-\ third\\:\\ 0\\.12419678956028403\ \(0\)\
\-\ to\\:\\ 0\\.12233366802057025\ \(0\)\
\-\ portion\\:\\ 0\\.11663924426410964\ \(0\)\
\-\ muscle\\:\\ 0\\.11582090681198254\ \(0\)\
\-\ enlarged\\:\\ 0\\.11119619437042198\ \(0\)\
\-\ inferior\\:\\ 0\\.11096834937203079\ \(0\)\
\-\ resection\\:\\ 0\\.10455745167803181\ \(0\)\
\-\ approximately\\:\\ 0\\.10407786985340103\ \(0\)\
\-\ during\\:\\ 0\\.1033153074355491\ \(0\)\
\-\ enhancing\\:\\ 0\\.10218046024501097\ \(0\)\
\-\ yo\\:\\ 0\\.1019036488286083\ \(0\)\
\-\ and\\:\\ 0\\.10111581357080884\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09714379556612578\ \(0\)\
\-\ cm\\:\\ 0\\.09367755372510868\ \(0\)\
\-\ mild\\:\\ 0\\.09246403091236963\ \(0\)\
\-\ anterior\\:\\ 0\\.09107267773585771\ \(0\)\
\-\ associated\\:\\ 0\\.08597269791791644\ \(0\)\
\-\ tumor\\:\\ 0\\.08531747850693613\ \(0\)\
\-\ surgical\\:\\ 0\\.07927816048398342\ \(0\)\
\-\ presents\\:\\ 0\\.07846569509359483\ \(0\)\
\-\ male\\:\\ 0\\.072624110581286\ \(0\)\
\-\ as\\:\\ 0\\.06552821635133363\ \(0\)\
\-\ with\\:\\ 0\\.0638790661650492\ \(0\)\
\-\ of\\:\\ 0\\.06384092122982682\ \(0\)\
\-\ history\\:\\ 0\\.062318547207756966\ \(0\)\
\-\ was\\:\\ 0\\.05684643927434856\ \(0\)\
\-\ patient\\:\\ 0\\.0530524180675814\ \(0\)\
